Diagnosis and Management of Early Pregnancy Loss
Kurt Barnhart MD, MSCE
William Shippen Jr, Professor of Obstetrics and Gynecology Penn Fertility Care Perlman School of Medicine at the University of Pennsylvania
Diagnosis and Management of Early Pregnancy Loss Kurt Barnhart MD, - - PowerPoint PPT Presentation
Diagnosis and Management of Early Pregnancy Loss Kurt Barnhart MD, MSCE William Shippen Jr, Professor of Obstetrics and Gynecology Penn Fertility Care Perlman School of Medicine at the University of Pennsylvania Objectives How does
William Shippen Jr, Professor of Obstetrics and Gynecology Penn Fertility Care Perlman School of Medicine at the University of Pennsylvania
How does one distinguish and ongoing IUP from a miscarriage and an ectopic pregnancy? What is a pregnancy of unknown location, and what do I do about it?
Once I make a diagnosis is it better to treat surgically, medically or use expectant management NO Disclosures
This ultrasound image shows an empty endometrial cavity and a 5-mm gestational sac in the right adnexa.
Intrauterine pregnancy 198 (59.0%) 200 (60.0%) Miscarriage 57 (17.0%) 82 (24.6%) Ectopic pregnancy 19 (6.0%) 27 (8.0%) Non-diagnostic 59 (18.0%) ____ Lost to follow-up _____ 22 (6.6%) Other _____ 2 (0.6%) Total 333 (100%) 333 (100%)
Patients with bhCG level ABOVE 1500 mIU/mL at presentation Ultrasound Diagnosis Sensitivity Specificity +PV
Intrauterine pregnancy 98%* 90% 96% 96% Miscarriage 73%* 93% 65% 65% Ectopic pregnancy 80%* 99% 86% 99%
Patients with bhCG level BELOW 1500 mIU/mL at presentation Ultrasound Diagnosis Sensitivity Specificity +PV
Intrauterine pregnancy 33%* 98% 80% 86% Miscarriage 28%* 100% 100% 47% Ectopic pregnancy 25%* 96% 60% 85%
Classification scheme for women with a positive pregnancy test at first TVS
Extrauterine gestational sac with yolk sac and/or embryo (with or without cardiac activity)
Definite Ectopic Pregnancy
Inhomogeneous adnexal mass or extrauterine sac-like structure
Probable Ectopic Pregnancy
No signs of intrauterine
sonography
Pregnancy of Unknown Location
Intrauterine gestational sac with yolk sac and/or embryo (with or without cardiac activity)
Definite Intrauterine Pregnancy
Intrauterine echogenic sac-like structure
Probable Intrauterine Pregnancy
1 in 200 (4.5 per 1000 pregnancies)
IUP Ectopic Pregnancy Abnormal IUP Nonviable intrauterine pregnancy + chorionic villi Ectopic pregnancy
D+C hCG>discriminatory zone transvaginal ultrasound when > discrim zone Normal rise Nonviable IUP + chorionic villi Ectopic pregnancy
D+C Plateau Follow to hCG=0 Normal fall Serial quantitative hCG hCG<discriminatory zone Nondiagnostic Transvaginal Ultrasound
Figure 1. Algorithm for the diagnosis of ectopic pregnancy in a hemodynamically stable patient
Barnhart et al Obstet Gynecol 1994; 84:1010-5 Gracia C, Barnhart KT. Obstet Gynecol, 97(3):464-470, 2001.
positive, and she THINKS she is about 2 weeks late for her period.
been spotting for 4 days
2 4 6 8 10 12 loghcg/99% CI/Fitted values 20 30 40 50 gestational age (days) loghcg 99% CI Fitted values
Number Of Days Since Presentation hCG (mIU/mL) 2 4 6 8 10 12 5000 10000 15000
Estimated Curve 15 % Lower Bound 5 % Lower Bound 1 % Lower Bound
Barnhart KT. Symptomatic Patients with an Early Viable Intrauterine Pregnancy; hCG Curves Redefined. Obstet Gynecol 2004;104:50-5.
Barnhart KT. Symptomatic Patients with an Early Viable Intrauterine Pregnancy; hCG Curves Redefined. Obstet Gynecol 2004;104:50-5.
2 4 6 8 10 12 20 30 40 50 gestational age (days) singleton twins triplets
23
The slopes by race
Fit the curve of women who presented to ED at risk for EP who were definitively diagnosed with a complete SAB 719 subjects, 2914 observations
Fit a number of models:
random intercept and random effect Final model was random linear effect dependant on initial hCG value
# of days after presentation drop of hCG 10 20 30 40 500 1000 1500 2000
Barnhart, K. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: Defining the normal curve. Ob Gyn 2004:104(5):975-981.
Intial hCG value hCG value at 2 days hCG value at 7 days hCG value at 21 days Time to neg hCG 500 256 447 (21%) 48 337 (60%) 76 19 1000 513 894 96 675 308 21 2000 1027 1788 193 1351 616 23 5000 2567 4470 (35%) 484 3378 (84%) 5 1541 26
Barnhart, K. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: Defining the normal curve. Ob Gyn 2004:104(5):975-981.
1543 patients (no apparent dx at presentation, + ß-hCG) 366 with EP
121 rising ß-hCG (60%) Group A 79 declining ß-hCG (40%) Group B
Group A (Rising ß- hCG) Group B (Declining ß-hCG) p
3.53 3.51 < 0.93 Days to Dx 5.34 5.29 < 0.72 ß-hCG presentation 700.36 1287.68 < 0.006 ß-hCG dx 1391.55 991.61 < 0.21 EGA presentation 38.96 42.72 < 0.19 EGA dx 44.30 48.13 < 0. 36
Number of days since presentation log(hCG) 0.0 0.5 1.0 1.5 2.0 2.5 3.0 2 4 6 8 10
1st percentile of IUP 90th percentile of SAB
Rising EP, 75% Rising EP, 90%
Number of days since presentation log(hCG) 0.0 0.5 1.0 1.5 2.0 2.5 3.0 2 4 6 8 10
1st percentile of IUP 90th percentile of SAB
Number of days since presentation log(hCG) 0.0 0.5 1.0 1.5 2.0 2.5 3.0 2 4 6 8 10
1st percentile of IUP 90th percentile of SAB
Dropping EP, 10%
Number of days since presentation log(hCG) 0.0 0.5 1.0 1.5 2.0 2.5 3.0 2 4 6 8 10
1st percentile of IUP 90th percentile of SAB
20%
Minimal Rise of β-hCG in IUP
Days since presentation hCG (mIU/mL)
min hCG Pt 1
Days since presentation hCG (mIU/mL)
min hCG Pt 2
Confidence interval bounds used for curves (percentile) Sensitivity for EP (%) Sensitivity for IUP (%) Mean number of days saved (range)* Mean number of visits saved (range)* Validation Original Validation Original Validation Original Validation Original IUP (0.999), SM (0.90) 83 83 92 95 2.87 (0-35) 2.64 (0-34) 0.92 (0-7) 1.22 (0-9) IUP (0.99), SM (0.90) 91 88 83 90 3.27 (0-35) 2.85 (0-34) 1.07 (0-7) 1.30 (0-9) IUP (0.95), SM (0.90) 92 91 73 78 3.44 (0-37) 2.94 (0-34) 1.12 (0-7) 1.35 (0-9) IUP (0.999), SM (0.95) 78 79 92 94 2.68 (0-35) 2.36 (0-34) 0.86 (0-7) 1.12 (0-9) IUP (0.99), SM (0.95) 86 84 83 90 3.08 (0-35) 2.60 (0-34) 1.02 (0-7) 1.21 (0-9) hCG, human chorionic gonadotropin; EP, ectopic pregnancy; IUP, intrauterine pregnancy; SM, spontaneous miscarriage. *For patients with outcome of ectopic pregnancy.
#Seeber et al. Fertil Steril 2006 Aug;86(2):454-9.
Confidence interval bound was defined as the minimal expected rise for an intrauterine pregnancy or fall for a spontaneous miscarriage.
Performance for Various hCG Cutoffs to Predict the Outcome in PUL
Confidence interval bounds used for curves (percentile) Number of misclassified EPs (%) Number of misclassified IUPs(%) Number of misclassified miscarriages (%) Validation Original# Validation Original Validation Original IUP (0.999), SM (0.90) 30 (16.8) 34 (17.3) 20 (7.7) 12 (4.6) 221 (39.0) 222 (28.0) IUP (0.99), SM (0.90) 16 (8.9) 24 (12.2) 45 (17.4) 26 (10.0) 231 (40.7) 224 (28.2) IUP (0.95), SM (0.90) 14 (7.8) 18 (9.2) 71 (27.4) 58 (22.2) 236 (41.6) 225 (28.4) IUP (0.999), SM (0.95) 39 (21.8) 41 (20.9) 20 (7.7) 15 (5.7) 163 (28.8) 158 (19.9) IUP (0.99), SM (0.95) 25 (14.0) 31 (15.8) 45 (17.4) 26 (10.0) 173 (30.5) 160 (20.2)
Performance for Various hCG Cutoffs to Predict the Outcome in PUL
#Seeber et al. Fertil Steril 2006 Aug;86(2):454-9.
Confidence interval bound was defined as the minimal expected rise for an intrauterine pregnancy or fall for a spontaneous miscarriage.
ultrasound that says she as a:
4 cm cystic adnexal mass No evidence of a gestational sac in the uterus
ultrasound that says she as a:
4 cm complex adnexal mass with increase
vascularity noted by Doppler (with a possible “ring of fire”.
No evidence of a gestational sac in the uterus
Ultrasound: No evidence of a gestational sac
in the uterus
hCG 6830
How often does it happen
Barnhart KT, Obstet Gynecol 2002;100(3):505-510.
Miscarriage N = 66 (38.2%) Ectopic N = 107 (61.8%) p Rise >10% 14 (25.5) 41 (75.5) 0.09 Plateau (+/- 10%) 27 (42.2) 37 (57.8) Fall > 10% 16 (44.4) 20 (55.6) hCG < 2000 40 (30.1) 93 (69.9) 0.01 hCG ≥ 2000 26 (65.0) 14 (35.0) Pain 0.84 hCG < 2000 22 (31.9) 47 (68.1) hCG ≥ 2000 12 (52.2) 11 (47.8) Bleedinge 0.52 hCG < 2000 23 (28.1) 59 (71.9) hCG ≥ 2000 20 (69.0) 9 (31.0) 2004 -2007
EP (n = 235) SAB (n = 86) OR for EP p All patients 235 (73.2%) 86 (26.8%) hCG< 2000 163 (69.4%) 32 (37.2%) 3.82 (2.28 - 6.41) <0.001 hCG > 2000 72 (30.6%) 54 (62.8%)
Evidence of intrauterine pregnancy on TVS Should be classified as viable, viability uncertain or nonviable
Histological Intrauterine Pregnancy
Chorionic villi identified in contents of uterine evacuation
Resolved Persistent PUL
Spontaneous resolution of hCG levels with expectant management or after uterine evacuation without evidence
Persisting PUL
Visualized Ectopic Pregnancy Spontaneously Resolved PUL Visualized Intrauterine Pregnancy
Evidence of ectopic pregnancy on transvaginal sonography (TVS)
Spontaneous resolution
hCG levels
Pregnancy of Unknown Location (PUL)
Non-Visualized Ectopic Pregnancy
Persistent or rising hCG levels after uterine evacuation
Treated Persistent PUL
Medical management of PUL without confirmation of the location of the gestation
Intrauterine Pregnancy
Visualized Intrauterine Pregnancy Evidence of intrauterine pregnancy on TVS Should be classified as viable, viability uncertain or nonviable Histological Intrauterine Pregnancy Chorionic villi identified in contents
Treated PUL
Treated Persistent PUL Medical management of PUL without confirmation of the location
Resolved PUL
Spontaneously Resolved PUL Spontaneous resolution of hCG levels Resolved Persistent PUL Spontaneous resolution of hCG levels with expectant management or after uterine evacuation without evidence
Ectopic Pregnancy
Visualized Ectopic Pregnancy Evidence of ectopic pregnancy on transvaginal sonography (TVS)
Non-visualized Ectopic Pregnancy Persistent or rising hCG levels after uterine evacuation
Pregnancy of Unknown Location (PUL)
Single Dose Multiple Dose Success 88% (940/1067) 93% (241/260) Range 86% - 90% 86% - 96% 40% of 862 subjects met inclusion criteria
Barnhart KT, Ashby RK, Gosman GG, Sammel M Obstet Gynecol, 2003;101(4):778-84
Successful treatment-no surgery for EP (N=101) 88 (87%) Successful treatment-no rupture of EP (N=101)* 98 (97%) Success with 1 course (2 doses) (N=88) 73 (83%) Needed more than 2 doses (n=88) 12 (14%) Treated for persistent EP (n=88)** 3 (3%) *4 women and 2 MDs elected surgery **4 cases of persistent EP treated with surgery
Cost, Efficacy and Incremental Cost Effectiveness Ratios (ICER) for Surgical versus Medical Treatment,
Strategy Cost (USD) Incremental Cost Efficacy Incremental Efficacy ICER All surgery Medication $563.4
$899.4 $335.9 0.968 0.124 $2,707 EVA alone Medication $563.4
$1,308.8 $745.4 0.977 0.134 $5,580 MVA alone Surgery $361.0
$563.4 $202.4 0.844
Dominated
Cost, Efficacy and Incremental Cost Effectiveness Ratios for Surgical versus Medical Treatment, by Miscarriage Type
Strategy Cost (USD) Incremental Cost Efficacy Incremental Efficacy ICER Fetal demise group Medication $511.9
$957.8 $445.9 0.979 0.101 $4,415 Anembryonic gestation Medication $617.6
$842.1 $224.4 0.962 $875 $1,445 Incomplete gestation Medication $523.1
$718.8 $195.7 0.876
Dominated
One-way sensitivity analysis
Two-way sensitivity analysis
Systematic evaluation of women at risk can assist in the prompt and accurate diagnosis of ectopic pregnancy Use of algorithm should never replace clinical acumen New clinical rules are “user friendly”